from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3855/ethR

LFCtreatmentdescriptionclass of inhibitor

0.507

Amikacinug/mL Amikacintranslation

0.663

Cap5-10ug/mL Capreomycintranslation

1.209

Rox10-50 ug/mL Roxithromycintranslation

-0.047

SM2-5 ug/mL Streptomycintranslation

0.314

Tet5-10 ug/mL Tetracyclinetranslation

-2.116

Rif0.2-5ug/mL Rifampicintranscription

-0.884

Rifp0.1-0.5ug/mL Rifapentinetranscription

2.209

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.377

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.346

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.111

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.367

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.858

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.814

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.135

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.341

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.182

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.130

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.301

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.440

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.991

KCN5-20 ug/mL Potassium cyaniderespiration

-0.431

NaN30.2-2 mM Sodium aziderespiration

0.388

Nigericin50 uM Nigericinrespiration

-0.160

TRC10-150 ug/mL Triclosanrespiration

0.286

TRZ10-25 ug/mL Thioridazinerespiration

0.642

Valinomycin0.5-10 uM Valinomycinrespiration

0.333

ZnSO42 mM ZnSO4respiration

0.094

menadione6-10 ug/mL Menadionerespiration

-0.146

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.164

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.131

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.141

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.198

NRP_1Non-replicating persistence stage 1dosRassociated

-0.182

Amp0.2mg/mL AmpicillincellWall

-0.439

Cephalexin20-100 ug/mL CephalexincellWall

-0.255

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.402

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.303

EMB10-20 ug/mL EthambutolcellWall

0.006

Eta12-40 ug/mL EthionamidecellWall

0.298

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.447

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.115

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.531

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.135

BZA0.12 mg/mL BenzamidearomaticAmides

0.458

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.573

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-1.002

H2O24 mM hydrogen peroxideDNAdamaging

-0.365

Levo10 ug/mL LevofloxacinDNAdamaging

-0.834

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.078

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.467

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.690

UVUV-irradiationDNAdamaging

0.974

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.361

Antimycin12.5-50 ug/mL Antimycin A?

-0.487

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.546

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.316

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.910

PA8240.2-2 ug/mL PA-824?

2.932

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

1.327

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.187

Verapamil50 uM Verapamil?

-0.683

mercaptoethanol2 mM 2-Mercaptoethanol?

0.612

methoxatin10-20 ug/mL Methoxatin?